An autoantibody associated with systemic lupus erythematosus may help improve the performance of immune checkpoint inhibitor ...

The most common cancer in women — and one of the deadliest — may have finally met its match. Development of a breakthrough ...

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

A new study reveals that the SARS-CoV-2 nucleocapsid protein can spread from infected to uninfected cells, triggering an ...

Results from the Phase II VLA1553-221 trial show that a full dose of Ixchiq demonstrated a 96.5% seroresponse rate in ...

The FDA recently granted fast track designation to PHST001, an investigational anti-CD24 monoclonal antibody, for the ...

Canine leishmaniosis, caused by Leishmania infantum, is a vector-borne disease. The immune response in infected dogs determines the clinical outcome, with a strong cell-mediated immune response linked ...

Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...

Antibody discovery, crucial for developing targeted therapies in fields like oncology and autoimmune diseases, is evolving ...

After Bicara reported a 12-month OS of 61% for its HPV-negative population last week, biotech Merus shared that its ...

DataM Intelligence | competitive Intelligence ITP affects 2–5/100k yearly. New therapies like BTK, FcRn blockers aim for lasting remission, ...